Clinical Trials Browser

Phase 4 × INDUSTRY × Granulocyte Colony-Stimulating Factor × Clear all

NCT01649635 2016-07-06

PROSPECTA

Phase 4 Completed

Prostatic Neoplasms

NCT01164475 2014-02-25

Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms

Phase 4 Completed

61 enrolled 19 charts

Lymphoma, Non-Hodgkin